Invention Grant
- Patent Title: Heteroarylsulfonyl-substituted pyridines and their use in the treatment of cancer
-
Application No.: US16484039Application Date: 2018-02-07
-
Publication No.: US11028067B2Publication Date: 2021-06-08
- Inventor: Benjamin Pelcman , Edgars Suna , William Stafford , Martins Priede
- Applicant: Oblique Therapeutics AB
- Applicant Address: SE Göteborg
- Assignee: Oblique Therapeutics AB
- Current Assignee: Oblique Therapeutics AB
- Current Assignee Address: SE Göteborg
- Agency: McCarter & English, LLP
- Agent Steven G. Davis; Mei Bai
- International Application: PCT/GB2018/050343 WO 20180207
- International Announcement: WO2018/146469 WO 20180816
- Main IPC: C07D401/12
- IPC: C07D401/12 ; A61K31/444 ; A61P35/00 ; C07D417/12
Abstract:
There is provided compounds of formula I (I) or pharmaceutically-acceptable salts thereof, wherein L, R1, R2, R3 and X have meanings provided in the description, which compounds are useful in the treatment of cancers.
Public/Granted literature
- US20200223819A1 HETEROARYLSULFONYL-SUBSTITUTED PYRIDINES AND THEIR USE IN THE TREATMENT OF CANCER Public/Granted day:2020-07-16
Information query
